First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?

Details

Request a copyRequest a copy
Serval ID
serval:BIB_FCBB794FB641
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?
Journal
Journal of clinical oncology
Author(s)
Uprety D., Remon J., Peters S.
ISSN
1527-7755 (Electronic)
ISSN-L
0732-183X
Publication state
Published
Issued date
01/02/2024
Peer-reviewed
Oui
Volume
42
Number
4
Pages
378-382
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
This article provides valuable insights into the use of dual immunotherapy for patients with metastatic NSCLC.
Keywords
Humans, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/pathology, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Immunotherapy
OAI-PMH
oai:serval.unil.ch:BIB_FCBB794FB641
DOI
10.1200/JCO.23.01524
Pubmed
38033277
Create date
04/12/2023 15:22
Last modification date
13/02/2024 8:23
Usage data